Bayer invests $2.2 billion in US vaccine manufacturing
Statements (4)
- Bullish
Bayer is investing $2.2 billion in a pharmaceutical site in the United States.
- Bullish
Bayer is investing billions of dollars in US pharmaceutical research and development.
- Neutral
Bayer AG is investing up to $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio
- Neutral
Bayer is investing $2.2 billion in a US drug plant to produce vaccines against COVID-19